Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis? Lanthier N. Clin Res Hepatol Gastroenterol 2025;49:102640.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lanthier N. Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis? Clin Res Hepatol Gastroenterol 2025;49:102640.
PMID: 40523520